MyJSCAI

🚨Exciting News! #JSCAI is accepted for PubMed Central Indexing!🎉

Read @AlexandraLansky's editorial:
➡️doi.org/10.1016/j.jsca…

📢This significant milestone boosts our authors' visibility, citation rates, and recognition by making all articles more accessible to researchers and practitioners.

♥️Thank you to our Editors, Authors, Reviewers, and everyone for their unwavering support in making this possible. @SCAI

📖 New insights from PEERLESS #LBMT: patients w substantial contraindications to #thrombolysis had similar rates of in-hospital death,intracranial hemorrhage, & major bleeding as randomized patients, despite higher bleeding risks. Read more ⬇️

➡️ jscai.org/article/S2772-…

#mechanicalthrombectomy #pulmonaryembolism
#thrombolysiscontraindication #MT #PE

@StefanStortecky @wissamj123 @jaygirimd @SameerKhandhar @carin_gonsalves

▶️ Watch now: @sahilparikhmd Andrew Holden, Sameh Sayfo @JDCorlMD @ZaidAlMarzooq discuss findings from the FORWARD #PAD studies & what the 1-year Javelin #IVLP findings could mean for challenging, difficult-to-cross lesions.

📺 youtu.be/3vJHQcI_Yec

📖SYMPHONY-PE trial: Despite higher baseline risk profiles, women undergoing aspiration #thrombectomy achieved comparable clot reduction, superior RV/LV recovery & similar safety outcomes compared with men. #pulmonaryembolism #sexdisparities Presented at #TCT2026 published in #JSCAI

➡️ jscai.org/article/S2772-…

@AqamarMD @AymenAhmed_ @SripalBangalore @vivianbishay

📖#TAVR use increased substantially among patients <70, driven by those aged 60–69, while #SAVR remained predominant. #StructuralHeart Presented at #TCT2026 published in #JSCAI

➡️ jscai.org/article/S2772-…

@potluri70 @mszerlip @karimalazizi